An interventional study of Cention N and Stela, SDI, Australia in Dental Caries and Primary Molars, sponsored by Al-Azhar University. Not yet recruiting. Open to participants aged 4 Years to 8 Years. Per ClinicalTrials.gov, last updated 2026-03-31.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Dental Caries by Al-Azhar University — 3 open to participants now, 5 under way, none of them phase 3. Dental Caries · Al-Azhar University.
Among the 17 studies in Dental Caries by Al-Azhar University, this one has the largest planned enrollment of the 16 interventional ones that give a count, is the only one that started in 2026, is one of 16 with no phase, and was the 17th registered.
1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →3 of the 17 studies in Dental Caries by Al-Azhar University are open now, in 1 country. Recruiting first, the newest first:
Al-Azhar University · Sites in Egypt
Ages 6–9
Al-Azhar University · Sites in Egypt
Ages 4–8
By country, each count listing its studies:
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 4 Years to 8 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 92 is above the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 36 across the 16 interventional studies, 1,224 across the 1 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Al-Azhar University is the lead sponsor of 536 studies on the registry; 172 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
1 of the studies in Dental Caries by Al-Azhar University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06767670Al-Azhar UniversityBacterial Colonization, Gingival Health, and Surface Roughness of Three Crown Types in Children's Teeth | 2027-11-01 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Dental Caries by Al-Azhar University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized clinical trial aims to compare the clinical and radiographic performance of four direct restorative materials used for restoring carious primary molars in children. Eligible children aged 4-8 years with posterior primary molars requiring direct restoration will be randomly allocated (1:1:1:1) to receive one of the following materials: an alkasite restorative material (Cention N), a self-cure bulk-fill resin composite (Stela; SDI), a conventional light-cured nanohybrid resin composite (Beautifil II), or a resin-modified glass ionomer cement (Riva Light Cure). Restorations will be evaluated using the Fédération Dentaire Internationale (FDI) World Dental Federation criteria. Postoperative sensitivity will be assessed at 48 hours using a 0-10 visual analogue scale (VAS). Clinical and radiographic follow-up assessments will be conducted at baseline and at scheduled recall visits
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Cention N
Device: Stela, SDI, Australia
Device: Beautifil II, Shofu, Japan
Device: Resin modified glass ionomer cement
Alkasite restorative material (Cention N) used for direct restoration of carious primary molars according to the manufacturer's instructions.
Also known as: Ivoclar Vivadent
Self-cure bulk-fill resin composite (Stela; SDI) used for direct restoration of carious primary molars according to the manufacturer's instructions.
Light-cured nanohybrid resin composite (Beautifil II) used for direct restoration of carious primary molars according to the manufacturer's instructions.
Resin-modified glass ionomer cement (Riva Light Cure) used for direct restoration of carious primary molars according to the manufacturer's instructions.
Restoration success based on FDI criteria (clinical and radiographic evaluation)
Time frame: 6 months
Restoration success based on FDI criteria (clinical and radiographic evaluation)
Clinical and radiographic success of restorations assessed using the Fédération Dentaire Internationale (FDI) World Dental Federation criteria (scores 1-5). Scores 1-3 are considered clinically acceptable; scores 4-5 are considered clinically unacceptable (repair or replacement indicated).
Time frame: 6 months
No study locations are listed for this record.
Plan to share: No — individual participant data will not be shared to protect participant privacy and confidentiality, in accordance with the informed consent provided by the participants and the ethical approval granted for this study
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Oct 2026, 6 months later.
Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 6 months is below that.
Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.